SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Monsanto Co.
MTC 2.025-13.8%Nov 17 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Anthony Wong who wrote (642)12/1/1998 12:31:00 PM
From: Dan Spillane  Read Replies (1) of 2539
 
If the following is correct, the partial news that was reported is a joke. Ha ha! I'm laughing. Let's mislead everyone! What is in question is not apparently related to the question of approval for most uses, only that the drug wouldn't be used for severe pain such as that after surgery. No kidding! Give me the Vicodin!

(from the news)
The second question, however, notes that the FDA doesn't
think there's enough evidence yet to support approval
specifically for ''acute pain,'' or the immediate treatment of
pain such as that following surgery. The question asks whether
the panel agrees.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext